Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

8.0K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
8.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

946
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
946

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational bottlenecks in blood-based proteomics.

EMBO molecular medicine·2026
Same author

Quantification of a serum titin fragment reflects dystrophin restoration in mdx mice and disease severity in patients with dystrophinopathies.

Journal of neuromuscular diseases·2026
Same author

A comparison of deep multiomics profiles across ethnicity, geography, and age.

Cell·2026
Same author

Longitudinal protein profiling of blood during childhood into early adulthood.

Nature communications·2026
Same author

Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations.

JHEP reports : innovation in hepatology·2026
Same author

HDAnalyzeR: streamlining data analysis for biomarker research.

Bioinformatics advances·2026
Same journal

Heparin to prevent recurrent placenta-mediated pregnancy complications in women with antiphospholipid syndrome: a systematic review.

Research and practice in thrombosis and haemostasis·2026
Same journal

Thromboembolic ischemic stroke induces neutrophil recruitment and matrix metalloproteinase-9 release to enhance ischemic brain injury.

Research and practice in thrombosis and haemostasis·2026
Same journal

Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleeding.

Research and practice in thrombosis and haemostasis·2026
Same journal

Antiphospholipid antibody formation during immune checkpoint inhibition in patients with cancer: a prospective cohort study.

Research and practice in thrombosis and haemostasis·2026
Same journal

Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis.

Research and practice in thrombosis and haemostasis·2026
Same journal

Identifying risk factors for venous thromboembolism in medical inpatients: a systematic review and meta-analysis.

Research and practice in thrombosis and haemostasis·2026
See all related articles

Related Experiment Video

Updated: Sep 25, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K

Proteomics in thrombosis research.

Fredrik Edfors1,2, Maria Jesus Iglesias1, Lynn M Butler1,3,4,5

  • 1Science for Life Laboratory Department of Protein Science CBH KTH Royal Institute of Technology Stockholm Sweden.

Research and Practice in Thrombosis and Haemostasis
|May 2, 2022
PubMed
Summary
This summary is machine-generated.

Proteomics offers new ways to find plasma biomarkers for diagnosing and predicting venous thromboembolism (VTE). Advanced techniques can identify novel biomarkers, but careful validation is crucial for clinical use.

Keywords:
VTEbiomarkermass spectrometryplasma proteinproteomeproteomicsthrombosisvenous thromboembolism

More Related Videos

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.0K
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.0K

Related Experiment Videos

Last Updated: Sep 25, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.0K
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.0K

Area of Science:

  • Biochemistry
  • Biotechnology
  • Clinical Medicine

Background:

  • Clinical need for improved plasma biomarker tools for venous thromboembolism (VTE) diagnosis and risk prediction.
  • Potential for individualized treatment and prevention through plasma protein analysis.
  • Technological advancements enable large-scale plasma proteome study for biomarker discovery.

Purpose of the Study:

  • Review and provide perspectives on proteomics applications in thrombosis research.
  • Discuss affinity- and mass spectrometry-based methods for plasma biomarker identification in VTE.
  • Offer a future outlook on discovery strategies and emerging technologies for targeted proteomics.

Main Methods:

  • Review of affinity- and mass spectrometry-based proteomics methods.
  • Analysis of plasma proteome for biomarker identification.
  • Discussion of targeted and nontargeted proteomics approaches.

Main Results:

  • Technological advances facilitate broad screening of plasma proteome.
  • Identification of potential plasma protein biomarkers for VTE.
  • Highlighting the importance of orthogonal validation due to assay limitations.

Conclusions:

  • Proteomics holds significant potential for developing novel VTE biomarkers.
  • Careful consideration of assay limitations and validation is essential for clinical translation.
  • Emerging technologies promise advancements in targeted proteomics for thrombosis research.